Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience

To date, a recognized treatment for refractory membranous nephropathy (MN) has not been established. Recently, several reports have indicated the efficacy of rituximab as a novel treatment option. However, only a few published accounts exist of rituximab therapy for idiopathic MN (IMN) in the Asian...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Intern Med
Hlavní autoři: Katsuno, Takayuki, Ozaki, Takenori, Kim, Hangsoo, Kato, Noritoshi, Suzuki, Yasuhiro, Akiyama, Shinichi, Ishimoto, Takuji, Kosugi, Tomoki, Tsuboi, Naotake, Ito, Yasuhiko, Maruyama, Shoichi
Médium: Artigo
Jazyk:Inglês
Vydáno: The Japanese Society of Internal Medicine 2017
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5519470/
https://ncbi.nlm.nih.gov/pubmed/28674357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.56.7908
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky